BB Biotech Ventures
Europe, Zurich, Switzerland, Zürich
Description
BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices.
Investor Profile
BB Biotech Ventures has backed more than 48 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 10% of its total and boasts 12 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States, Switzerland, The Netherlands.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series C (23%)
- Series A (19%)
- Series B (19%)
- Series Unknown (13%)
- Series D (10%)
- Post Ipo Equity (6%)
- Series E (4%)
- Private Equity (4%)
- Series G (2%)
Country Focus
- United States (56%)
- Switzerland (23%)
- The Netherlands (6%)
- Germany (6%)
- Ireland (4%)
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
- Italy (4%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Health Diagnostics
- Medical Device
- Therapeutics
- Biopharma
- Women's
- Neuroscience
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
